|Day Low/High||4.12 / 4.22|
|52 Wk Low/High||3.92 / 13.61|
While the portfolio experienced some pain last week along with the broader market, 12 of our holdings beat the Russell 2000 either on an absolute or relative basis.
We will buy more shares of Encana as the company executed the second quarter well on several levels.
Company generates free cash flow and growing margins through cost management and strong production Second quarter 2019 highlights: Financial performance driven by strong liquids production and cost focus.
We exited a position last week for a nice gain as the market continued to rise.
As the momentum of earnings season rose last week, we made several trades including initiating a new position in Innovative Solutions and Support.
CALGARY, July 16, 2019 /PRNewswire/ - Encana Corporation (NYSE, TSX: ECA) plans to release its 2019 second quarter financial and operating results prior to market open on Wednesday, July 31, 2019.
We added to one position last week as as the small-cap heavy Russell 2000 dipped.
Our latest strategy on underachieving Encana and high-flying Pareteum.
We added to one position and initiated another during a shortened holiday week.
CALGARY, July 8, 2019 /PRNewswire/ - Encana Corporation (NYSE, TSX: ECA) today is commencing its previously announced substantial issuer bid ("the Offer") to purchase for cancellation up to US$213 million of its common shares ("Shares").
CALGARY, July 8, 2019 /PRNewswire/ - Encana Corporation (NYSE, TSX: ECA) today announced that its wholly owned subsidiary, Newfield Exploration Mid-Continent Inc.
We initiated a new position and added to a couple of others as we closed the books on the second quarter.
We will buy more shares of Encana as an act of self-defense based on a finally changing technical picture.
Last week we started two new positions, trimmed a winner and exited another name as the markets moved higher across the board.
With the market rising last week, we saw favorable action in several of our holdings and booked some hefty gains in one name.
With the market rebounding, the majority of our positions rose week over week.
Encana repurchased 10% of its outstanding shares year-to-date; Plans to commence additional buyback in July 2019 Recent strong well performance in STACK strengthens the Company's second quarter 2019 production outlook Company reiterates annual capital...
During the week, we exited our position in KushCo Holdings and initiated Antares Pharma.
Several positive moves along with our cash position helped insulate the overall portfolio’s performance from last week's market decline.
Amid renewed trade and geopolitical tensions, we trimmed our position in Energy Recovery and added a short-term trade in J.C. Penney.
We took some nice profits trimming a position, exited a name and added to another holding during a challenging week for stocks.
We added to three positions and pulled the plug on another during a solid week for small-cap stocks.
We are adding to Encana and Pareteum, which oddly have been Sarge’s best and worst performers in the portfolio.
Encaca Corp. reports first-quarter results that disappointed investors, though there were positives for the oil and gas producer.
We ditched one position and added to another last week as small-cap stocks trended higher.
We're disappointed with the performance of VirTra Inc. and are exiting the stock, using some of the proceeds to buy more shares of Encana Corp.
During the week, we took a starter position in Encana Corp. and boosted our cash position by trimming iShares Russell 2000 ETF.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.